Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results

Q2 Fiscal 2024 Highlights
Cash position of $6.6 million as of February 29, 2024Gross profit of $0.5 million, a 22.7% decline over Q1 2024Revenue of $5.0 million, a 15.4% decline over Q1...

Related Keywords

United States ,Canada ,Oregon ,Phoenix ,Arizona ,Vancouver ,British Columbia ,Utah ,Canadian ,America ,Donna Wong ,Rick Doblin ,Donna Wilson ,Paul Thielking ,Payton Nyquvest ,Reid Robison ,Melony Valleau ,Nikhil Handa ,Numinus Clinical Research ,Numinus Training Program ,Linkedin ,Facebook ,Twitter ,Psychedelics Drug Development Tracker ,Numinus Wellness Inc ,Numinu Cedar Clinical Research ,Numinus Wellness Clinic Network ,Company Phoenix ,Cedar Clinical Research ,Oregon Health Authority ,Clinical Trial Application To Health Canada ,Multidisciplinary Association For Psychedelic Studies ,Instagram ,Cedar Clinical ,Numinus Wellness ,Clinical Trial Application ,Health Canada ,Numinus Founder ,Numinus Training ,Multidisciplinary Association ,Psychedelic Studies ,Edwin Garner ,Chief Clinical Officer ,Numinu Chief Science Officer ,Chief Medical ,Numinu Investor Relations ,Prescription Drug User Fee Act ,Accessed April ,Numinu Board ,Stifel Canada ,Toll Free North America ,Markets ,